Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors

References

• Kos-Kudła B, Rosiek V, Borowska M, et al. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2017;68:169–197. doi:10.5603/EP.2017.2016
   PubMed Web of Science ®Google Scholar
• Scott AT, Howe JR. Evaluation and management of neuroendocrine tumors of the pancreas. Surg Clin North Am. 2019;99(4):793–814. doi:10.1016/j.suc.2019.04.014
   PubMed Web of Science ®Google Scholar
• Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–1342. doi:10.1001/jamaoncol.2017.0589
   PubMed Web of Science ®Google Scholar
• Kaltenborn A, Matzke S, Kleine M, et al. Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms. J Surg Oncol. 2016;113:194–202. doi:10.1002/jso.24116
   PubMed Web of Science ®Google Scholar
• Mei W, Ding Y, Wang S, Jia Y, Cao F, Li F. Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes. J Cancer Res Clin Oncol. 2020;146:3049–3061. doi:10.1007/s00432-020-03303-w
   PubMed Web of Science ®Google Scholar
• Regenet N, Carrere N, Boulanger G, et al. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: a French multicenter study. Surgery. 2016;159:901–907. doi:10.1016/j.surg.2015.10.003
   PubMed Web of Science ®Google Scholar
• Marchegiani G, Landoni L, Andrianello S, et al. Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? Neuroendocrinology. 2019;108(3):161–171.
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072. doi:10.1200/JCO.2007.15.4377
   PubMed Web of Science ®Google Scholar
• Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139:2679–2686. doi:10.1002/ijc.30400
   PubMed Web of Science ®Google Scholar
• Belotto M, Crouzillard BDNS, Araujo KO, Peixoto RD. Pancreatic neuroendocrine tumors surgical resection. Arq Bras Cir Dig. 2019;32(1):e1428. doi:10.1590/0102-672020180001e1428
   PubMed Web of Science ®Google Scholar
• Lim TY, Leitman IM. Risk factors for early morbidity and mortality following pancreatoduodenectomy with concomitant vascular reconstruction. Ann Med Surg. 2021;68:102587. doi:10.1016/j.amsu.2021.102587
   PubMed Web of Science ®Google Scholar
• Kuo EJ, Salem RR. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol. 2013;20(9):2815–2821. doi:10.1245/s10434-013-3005-7
   PubMed Web of Science ®Google Scholar
• Falconi M, Eriksson B, Kaltsas G, et al. ENETS Consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153–171. doi:10.1159/000443171
   PubMed Web of Science ®Google Scholar
• Falconi M, Bartsch DK, Eriksson B, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012;95:120–134. doi:10.1159/000335587
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–188. doi:10.1111/his.13975
   PubMed Web of Science ®Google Scholar
• Shah MH, Goldner WS, Halfdanarson TR, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors. J Natl Compr Canc Netw. 2018;16:693–702. doi:10.6004/jnccn.2018.0056
   PubMed Web of Science ®Google Scholar
• Lopez-Aguiar AG, Ethun CG, Zaidi MY, et al. The conundrum of < 2-cm pancreatic neuroendocrine tumors: a preoperative risk score to predict lymph node metastases and guide surgical management. Surgery. 2019;166:15–21. doi:10.1016/j.surg.2019.03.008
   PubMed Web of Science ®Google Scholar
• Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol. 2014;21:3515–3521. doi:10.1245/s10434-014-3769-4
   PubMed Web of Science ®Google Scholar
• Bar-Moshe Y, Mazeh H, Grozinsky-Glasberg S. Non-functioning pancreatic neuroendocrine tumors: surgery or observation? World J Gastrointest Endosc. 2017;16(9):153–161. doi:10.4253/wjge.v9.i4.153
   Web of Science ®Google Scholar
• Barenboim A, Lahat G, Nachmany I, et al. Resection versus observation of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors. J Gastrointest Surg. 2020;24:1366–1374. doi:10.1007/s11605-019-04285-y
   PubMed Web of Science ®Google Scholar
• Perri G, Prakash LR, Katz MHG. Pancreatic neuroendocrine tumors. Curr Opin Gastroenterol. 2019;35:468–477. doi:10.1097/MOG.0000000000000571
   PubMed Web of Science ®Google Scholar
• Partelli S, Mazza M, Andreasi V, et al. Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life. Surgery. 2019;166:157–163. doi:10.1016/j.surg.2019.04.003
   PubMed Web of Science ®Google Scholar
• McMillan MT, Christein JD, Callery MP, et al. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. Surgery. 2016;159:1013–1022. doi:10.1016/j.surg.2015.10.028
   PubMed Web of Science ®Google Scholar
• Heidsma C, Tsilimigras D, van Dieren S, et al. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. HPB. 2021;23:413–421. doi:10.1016/j.hpb.2020.06.015
   PubMed Web of Science ®Google Scholar
• Mauriello C, Napolitano S, Gambardella C, et al. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: literature review. Int. J Surg. 2015;21(Suppl 1):S10–4.
   Google Scholar
• Altimari M, Abad J, Chawla A. The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors. HPB (Oxford). 2021;23:1533–1540. doi:10.1016/j.hpb.2021.03.005
   PubMed Web of Science ®Google Scholar
• Howe JR, Merchant NB, Conrad C, et al. The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49:1–33. doi:10.1097/MPA.0000000000001454
   PubMed Web of Science ®Google Scholar
• Sadot E, Reidy-Lagunes DL, Tang LH, et al. Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study. Ann Surg Oncol. 2016;23:1361–1370. doi:10.1245/s10434-015-4986-1
   PubMed Web of Science ®Google Scholar
• Doi R. Determinants of surgical resection for pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:610–617. doi:10.1002/jhbp.224
   PubMed Web of Science ®Google Scholar
• Curran T, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection. J Gastrointest Surg. 2015;19:152–160. doi:10.1007/s11605-014-2624-z
   PubMed Web of Science ®Google Scholar
• Postlewait LM, Ethun CG, Baptiste GG, et al. Pancreatic neuroendocrine tumors: preoperative factors that predict lymph node metastases to guide operative strategy. J Surg Oncol. 2016;114:440–445. doi:10.1002/jso.24338
   PubMed Web of Science ®Google Scholar
• Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203. doi:10.1097/SLA.0000000000000348
   PubMed Web of Science ®Google Scholar
• Mintziras I, Keck T, Werner J, et al. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry. Surg Today. 2019;49(12):1013–1021. doi:10.1007/s00595-019-01838-1
   PubMed Web of Science ®Google Scholar
• Wang DS, Zhang DS, Qiu MZ, et al. Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas. Tumour Biol. 2011;32:697–705. doi:10.1007/s13277-011-0170-9
   PubMedGoogle Scholar
• Zhang Z, Liu M, Ji S, et al. Prognostic value and clinical predictors of lymph node metastases in pancreatic neuroendocrine tumors. Pancreas. 2020;49:381–386. doi:10.1097/MPA.0000000000001493
   PubMed Web of Science ®Google Scholar
• Vega EA, Kutlu OC, Alarcon SV, et al. Clinical prognosticators of metastatic potential in patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2021;25(10):2593–2599. doi:10.1007/s11605-021-04946-x
   PubMed Web of Science ®Google Scholar
• Beane JD, Borrebach JD, Billderback A, et al. Small pancreatic neuroendocrine tumors: resect or enucleate? Am J Surg. 2021;222(1):29–34. doi:10.1016/j.amjsurg.2020.12.013
   PubMed Web of Science ®Google Scholar
• Badarna M, Percik R, Aharon-Hananel G, Uri I, Tirosh A. Anatomic site as prognostic marker of pancreatic neuroendocrine tumors: a cohort study. Eur J Endocrinol. 2019;181(3):325–330.
   PubMed Web of Science ®Google Scholar